Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment

Abstract Background Exosomes are extracellular vesicles secreted by eukaryotic cells and have been extensively studied for their surface markers and internal cargo with unique functions. A deeper understanding of exosomes has allowed their application in various research areas, particularly in diagn...

Full description

Bibliographic Details
Main Authors: Eun Sook Lee, Hyewon Ko, Chan Ho Kim, Hyun-Chul Kim, Seong-Kyoon Choi, Sang Won Jeong, Se-Guen Lee, Sung-Jun Lee, Hee-Kyung Na, Jae Hyung Park, Jung Min Shin
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2023-08-01
Series:Biomaterials Research
Subjects:
Online Access:https://doi.org/10.1186/s40824-023-00418-2
_version_ 1827331711345623040
author Eun Sook Lee
Hyewon Ko
Chan Ho Kim
Hyun-Chul Kim
Seong-Kyoon Choi
Sang Won Jeong
Se-Guen Lee
Sung-Jun Lee
Hee-Kyung Na
Jae Hyung Park
Jung Min Shin
author_facet Eun Sook Lee
Hyewon Ko
Chan Ho Kim
Hyun-Chul Kim
Seong-Kyoon Choi
Sang Won Jeong
Se-Guen Lee
Sung-Jun Lee
Hee-Kyung Na
Jae Hyung Park
Jung Min Shin
author_sort Eun Sook Lee
collection DOAJ
description Abstract Background Exosomes are extracellular vesicles secreted by eukaryotic cells and have been extensively studied for their surface markers and internal cargo with unique functions. A deeper understanding of exosomes has allowed their application in various research areas, particularly in diagnostics and therapy. Main body Exosomes have great potential as biomarkers and delivery vehicles for encapsulating therapeutic cargo. However, the limitations of bare exosomes, such as rapid phagocytic clearance and non-specific biodistribution after injection, pose significant challenges to their application as drug delivery systems. This review focuses on exosome-based drug delivery for treating rheumatoid arthritis, emphasizing pre/post-engineering approaches to overcome these challenges. Conclusion This review will serve as an essential resource for future studies to develop novel exosome-based therapeutic approaches for rheumatoid arthritis. Overall, the review highlights the potential of exosomes as a promising therapeutic approach for rheumatoid arthritis treatment. Graphical Abstract
first_indexed 2024-03-07T16:44:14Z
format Article
id doaj.art-58fffaf930bc49e9bf1e6fbe20b9c39b
institution Directory Open Access Journal
issn 2055-7124
language English
last_indexed 2024-03-07T16:44:14Z
publishDate 2023-08-01
publisher American Association for the Advancement of Science (AAAS)
record_format Article
series Biomaterials Research
spelling doaj.art-58fffaf930bc49e9bf1e6fbe20b9c39b2024-03-03T06:55:04ZengAmerican Association for the Advancement of Science (AAAS)Biomaterials Research2055-71242023-08-0127113610.1186/s40824-023-00418-2Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatmentEun Sook Lee0Hyewon Ko1Chan Ho Kim2Hyun-Chul Kim3Seong-Kyoon Choi4Sang Won Jeong5Se-Guen Lee6Sung-Jun Lee7Hee-Kyung Na8Jae Hyung Park9Jung Min Shin10Safety Measurement Institute, Korea Research Institute of Standards and Science (KRISS)Bionanotechnology Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB)School of Chemical Engineering, Sungkyunkwan UniversityDivision of Biotechnology, Convergence Research Institute, DGISTDivision of Biotechnology, Convergence Research Institute, DGISTDivision of Biotechnology, Convergence Research Institute, DGISTDivision of Biotechnology, Convergence Research Institute, DGISTDivision of Biotechnology, Convergence Research Institute, DGISTSafety Measurement Institute, Korea Research Institute of Standards and Science (KRISS)School of Chemical Engineering, Sungkyunkwan UniversityDivision of Biotechnology, Convergence Research Institute, DGISTAbstract Background Exosomes are extracellular vesicles secreted by eukaryotic cells and have been extensively studied for their surface markers and internal cargo with unique functions. A deeper understanding of exosomes has allowed their application in various research areas, particularly in diagnostics and therapy. Main body Exosomes have great potential as biomarkers and delivery vehicles for encapsulating therapeutic cargo. However, the limitations of bare exosomes, such as rapid phagocytic clearance and non-specific biodistribution after injection, pose significant challenges to their application as drug delivery systems. This review focuses on exosome-based drug delivery for treating rheumatoid arthritis, emphasizing pre/post-engineering approaches to overcome these challenges. Conclusion This review will serve as an essential resource for future studies to develop novel exosome-based therapeutic approaches for rheumatoid arthritis. Overall, the review highlights the potential of exosomes as a promising therapeutic approach for rheumatoid arthritis treatment. Graphical Abstracthttps://doi.org/10.1186/s40824-023-00418-2ExosomeRheumatoid arthritisDisease microenvironmentEngineered exosome
spellingShingle Eun Sook Lee
Hyewon Ko
Chan Ho Kim
Hyun-Chul Kim
Seong-Kyoon Choi
Sang Won Jeong
Se-Guen Lee
Sung-Jun Lee
Hee-Kyung Na
Jae Hyung Park
Jung Min Shin
Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment
Biomaterials Research
Exosome
Rheumatoid arthritis
Disease microenvironment
Engineered exosome
title Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment
title_full Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment
title_fullStr Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment
title_full_unstemmed Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment
title_short Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment
title_sort disease microenvironment modulation by bare or engineered exosome for rheumatoid arthritis treatment
topic Exosome
Rheumatoid arthritis
Disease microenvironment
Engineered exosome
url https://doi.org/10.1186/s40824-023-00418-2
work_keys_str_mv AT eunsooklee diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT hyewonko diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT chanhokim diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT hyunchulkim diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT seongkyoonchoi diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT sangwonjeong diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT seguenlee diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT sungjunlee diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT heekyungna diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT jaehyungpark diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment
AT jungminshin diseasemicroenvironmentmodulationbybareorengineeredexosomeforrheumatoidarthritistreatment